MYGN Insider Transactions — Page 5
1,007 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 401–500; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| SKOLNICK MARK H | Chief Scientific Officer | 2009-02-27 | Sale | 9,000.0 | $80.36 |
| Capone Mark Christopher | Chief Operating Officer, MGL | 2009-02-09 | Sale | 6,750.0 | $85.4 |
| Capone Mark Christopher | Chief Operating Officer, MGL | 2009-02-09 | Sale | 9,062.0 | $85.4 |
| Capone Mark Christopher | Chief Operating Officer, MGL | 2009-02-09 | Sale | 6,081.0 | $85.4 |
| LANCHBURY JERRY S | Executive V.P. - Research | 2009-02-06 | Sale | 7,089.0 | $84.31 |
| LANCHBURY JERRY S | Executive V.P. - Research | 2009-02-06 | Sale | 2,911.0 | $84.31 |
| LANGER DENNIS | Director | 2009-02-05 | Sale | 10,000.0 | $82.72 |
| LANGER DENNIS | Director | 2009-02-05 | Sale | 5,000.0 | $82.72 |
| HENDERSON JOHN T | Director | 2009-02-05 | Sale | 10,000.0 | $82.46 |
| HOBDEN ADRIAN N | Pres. Myriad Pharmaceuticals | 2009-02-05 | Sale | 24,000.0 | $83.6 |
| MELDRUM PETER D | President & C.E.O. | 2009-02-05 | Sale | 15,000.0 | $83.14 |
| MARSH RICHARD M | V.P., General Counsel | 2009-02-04 | Sale | 237.0 | $85.0 |
| Harrison Robert Gardner | Chief Information Officer | 2009-02-03 | Sale | 1,800.0 | $85.0 |
| Harrison Robert Gardner | Chief Information Officer | 2009-02-03 | Sale | 200.0 | $85.0 |
| Harrison Robert Gardner | Chief Information Officer | 2009-02-03 | Sale | 2,000.0 | $80.0 |
| Evans James S | Chief Financial Officer | 2009-02-03 | Sale | 9,200.0 | $80.16 |
| Evans James S | Chief Financial Officer | 2009-02-03 | Sale | 1,764.0 | $79.2 |
| LANCHBURY JERRY S | Executive V.P. - Research | 2009-02-03 | Sale | 10,000.0 | $82.0 |
| CRITCHFIELD GREGORY C | President Myriad Genetic Labs | 2009-02-03 | Sale | 20,000.0 | $84.5 |
| MELDRUM PETER D | President & C.E.O. | 2009-02-03 | Sale | 4,000.0 | $84.57 |
| MELDRUM PETER D | President & C.E.O. | 2009-02-03 | Sale | 1,900.0 | $83.7 |
| MELDRUM PETER D | President & C.E.O. | 2009-02-03 | Sale | 1,100.0 | $82.61 |
| MELDRUM PETER D | President & C.E.O. | 2009-02-03 | Sale | 1,300.0 | $81.55 |
| MELDRUM PETER D | President & C.E.O. | 2009-02-03 | Sale | 758.0 | $80.36 |
| MELDRUM PETER D | President & C.E.O. | 2009-02-03 | Sale | 942.0 | $79.58 |
| MARSH RICHARD M | V.P., General Counsel | 2009-02-03 | Sale | 10,763.0 | $85.0 |
| MARSH RICHARD M | V.P., General Counsel | 2009-01-30 | Sale | 9,804.0 | $75.03 |
| MARSH RICHARD M | V.P., General Counsel | 2009-01-29 | Sale | 1,800.0 | $75.06 |
| CRITCHFIELD GREGORY C | President Myriad Genetic Labs | 2009-01-28 | Sale | 20,000.0 | $74.5 |
| LANCHBURY JERRY S | Executive V.P. - Research | 2008-12-18 | Sale | 5,000.0 | $67.0 |
| LANCHBURY JERRY S | Executive V.P. - Research | 2008-12-18 | Sale | 5,000.0 | $67.0 |
| HOBDEN ADRIAN N | Pres. Myriad Pharmaceuticals | 2008-12-11 | Sale | 20,000.0 | $60.6 |
| WILSON LINDA S | Director | 2008-12-09 | Sale | 8,000.0 | $63.91 |
| WILSON LINDA S | Director | 2008-12-09 | Sale | 8,000.0 | $63.91 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-11-10 | Sale | 10,000.0 | $71.15 |
| Laslie W Wayne | Chief Operating Officer, MPI | 2008-11-04 | Sale | 12,000.0 | $70.0 |
| MELDRUM PETER D | President & C.E.O. | 2008-11-04 | Sale | 2,082.0 | $71.25 |
| MELDRUM PETER D | President & C.E.O. | 2008-11-04 | Sale | 6,118.0 | $70.45 |
| MELDRUM PETER D | President & C.E.O. | 2008-11-04 | Sale | 1,800.0 | $69.09 |
| Evans James S | Chief Financial Officer | 2008-09-25 | Sale | 6,669.0 | $69.0 |
| HOBDEN ADRIAN N | Pres. Myriad Pharmaceuticals | 2008-09-25 | Sale | 15,000.0 | $68.54 |
| HOBDEN ADRIAN N | Pres. Myriad Pharmaceuticals | 2008-09-19 | Sale | 992.0 | $66.0 |
| WILSON LINDA S | Director | 2008-09-19 | Sale | 2,500.0 | $65.81 |
| WILSON LINDA S | Director | 2008-09-19 | Sale | 2,500.0 | $65.81 |
| WILSON LINDA S | Director | 2008-09-19 | Sale | 2,500.0 | $65.81 |
| WILSON LINDA S | Director | 2008-09-19 | Sale | 2,500.0 | $65.81 |
| WILSON LINDA S | Director | 2008-09-19 | Sale | 2,500.0 | $65.81 |
| HOBDEN ADRIAN N | Pres. Myriad Pharmaceuticals | 2008-09-17 | Sale | 500.0 | $66.49 |
| CRITCHFIELD GREGORY C | President Myriad Genetic Labs | 2008-09-17 | Sale | 1.0 | $66.08 |
| CRITCHFIELD GREGORY C | President Myriad Genetic Labs | 2008-09-17 | Sale | 32,379.0 | $66.08 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-09-16 | Sale | 5,000.0 | $66.0 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-09-16 | Sale | 14,500.0 | $66.0 |
| HOCKETT WILLIAM A III | V. P. of Corp Communications | 2008-09-08 | Sale | 12,204.0 | $64.04 |
| HOCKETT WILLIAM A III | V. P. of Corp Communications | 2008-09-08 | Sale | 12,253.0 | $64.04 |
| HOCKETT WILLIAM A III | V. P. of Corp Communications | 2008-09-08 | Sale | 3,990.0 | $64.04 |
| LANGER DENNIS | Director | 2008-09-05 | Sale | 4,280.0 | $63.5 |
| GILBERT WALTER PHD | Director | 2008-09-05 | Sale | 5,000.0 | $63.31 |
| GILBERT WALTER PHD | Director | 2008-09-05 | Sale | 5,000.0 | $63.31 |
| LANGER DENNIS | Director | 2008-09-04 | Sale | 5,720.0 | $65.73 |
| LANCHBURY JERRY S | Executive V.P. - Research | 2008-09-03 | Sale | 20,000.0 | $67.07 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-09-03 | Sale | 500.0 | $68.51 |
| Capone Mark Christopher | Chief Operating Officer, MGL | 2008-08-29 | Sale | 2,030.0 | $67.93 |
| Capone Mark Christopher | Chief Operating Officer, MGL | 2008-08-29 | Sale | 5,184.0 | $67.93 |
| Capone Mark Christopher | Chief Operating Officer, MGL | 2008-08-29 | Sale | 2,316.0 | $67.93 |
| Capone Mark Christopher | Chief Operating Officer, MGL | 2008-08-29 | Sale | 3,000.0 | $67.93 |
| Capone Mark Christopher | Chief Operating Officer, MGL | 2008-08-29 | Sale | 5,470.0 | $67.93 |
| MARSH RICHARD M | V.P., General Counsel | 2008-08-29 | Sale | 11,198.0 | $68.26 |
| MELDRUM PETER D | President & C.E.O. | 2008-08-29 | Sale | 15,998.0 | $68.07 |
| Harrison Robert Gardner | Chief Information Officer | 2008-08-27 | Sale | 1,526.0 | $65.9 |
| Harrison Robert Gardner | Chief Information Officer | 2008-08-27 | Sale | 2,199.0 | $65.9 |
| Harrison Robert Gardner | Chief Information Officer | 2008-08-27 | Sale | 360.0 | $65.9 |
| HOBDEN ADRIAN N | Pres. Myriad Pharmaceuticals | 2008-08-25 | Sale | 27,464.0 | $65.03 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 1,600.0 | $34.9 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 400.0 | $34.91 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 700.0 | $34.92 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 200.0 | $34.93 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 900.0 | $34.94 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 163.0 | $34.95 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 1,437.0 | $34.96 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 2,268.0 | $34.97 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 400.0 | $34.98 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 100.0 | $34.99 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 4,700.0 | $35.0 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 300.0 | $35.01 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 700.0 | $35.03 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 400.0 | $35.04 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 100.0 | $35.06 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 100.0 | $35.1 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 100.0 | $35.11 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 1,200.0 | $35.12 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 700.0 | $35.13 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 100.0 | $35.14 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 900.0 | $35.18 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 200.0 | $35.19 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 532.0 | $35.2 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 100.0 | $35.23 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 100.0 | $35.27 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 200.0 | $35.28 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 100.0 | $35.29 |
| SKOLNICK MARK H | Chief Scientific Officer | 2008-03-20 | Sale | 400.0 | $35.33 |